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Abstract 
ABSTRACT 
 
The complex of serum proteins known as complement plays key roles in the lytic and 
inflammatory properties of the immune system, including both innate and adaptive immunity. 
The last several years have seen an enormous expansion in our understanding of the details of 
complement biochemistry and in our appreciation of the role of complement proteins in 
biological phenomena. This observation particularly calls for the in vitro examination of 
complement proteins activity derived from blood serum of a defined group of urban and slum 
people against E. coli, a major cause of large scale epidemics and thousands of sporadic cases 
of gastrointestinal illness. In this exertion we attempt to make a comparative analysis on 
complement mediated killing of clinical isolates of E. coli, derived from serum collected 
from urban and slum population. However the slum population showed more effective 
complement mediated killing in comparison to urban population. 
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Introduction 
1. Introduction and Literature Review 
1.1 Background 
Escherichia coli or E. coli is a widely known species of bacteria from the family of gram 
negative bacteria- Enterobacteriaceae and genus- Escherichia. The genus was named after, 
German bacteriologist Theodor Escherich who discovered the organism from human colon in 
1885 [Feng et al., 2002]. Escherich was also the first to show that this organism has the 
ability to cause certain diseases like infant diarrhea, gastroenteritis etc. The organism was 
initially named Bacterium coli but later was changed into Escherichia coli to honor its 
discoverer [Feng et al., 2002]. It is a gram-negative, facultatively anaerobic, rod shaped 
bacterium found most commonly in lower intestines of warm blooded animals [Tortora et al., 
2012]. The “O” and “H” antigens on the bacteria and their flagella form different serotypes. 
There are now more than 700 serotypes of E. coli present [Griffin & Tauxe, 1991]. Most E. 
coli strains are harmless, even known as an essential organism to humans as they inhabit the 
gut area as normal flora to aid the hosts by producing vitamin K2 [Bentley & Meganathan, 
1982].The beneficial normal flora also protects the intestine of their host by preventing 
invasion by other pathogenic organisms. E. coli and other facultative anaerobes constitute 
about 0.1% of gut flora [Eckburg et al., 2005]. So fecal matter from a healthy individual 
contains a large amount of E. coli but the number reduces slowly. Though most kinds of E. 
coli do not cause disease in humans, some serotypes have the potential to cause infections of 
the gastrointestinal tract, urinary tract etc. of their hosts [Eisenstein & Zaleznik, 2000]. E. coli 
is the major cause of some mild and severe diarrhea [Bower et al., 1999]. The minor 
infections and severe diseases occur when the pathogenic strain of the bacterium (for e.g. E. 
coliO157:H7) enters host through fecal-oral route. E. coli O157:H7 has proved to be one of 
the most dangerous strains that have a high prevalence of illnesses throughout the world. This 
strain produces a toxin called shiga toxin that is similar to the toxin produced by Shigella 
dysenteriae. The toxin has the ability to inhibit protein synthesis which leads to the death of 
cells. This killing of cells leads to a breakdown of the lining and to hemorrhage. The first 
response is commonly a bloody diarrhea. The toxin also disrupts small blood vessels, mainly 
the glomerulus which leads to kidney failure and the development of the often hemolytic 
uremic syndrome. The toxin has effect on lungs and as well as the nervous system. Shiga 
toxin–producing E. coli (STEC) cause approximately 100,000 illnesses, 3,000 
hospitalizations, and 90 deaths annually in the United States [Mead et al., 1999 & CDC, 
2009]. E. coli cells are able to survive outside the body for a limited amount of time, which 
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makes them potential indicator organisms to test environmental samples for fecal 
contamination [Feng et al., 2002]. But persistent E. coli has demonstrated that they can 
survive in the environment, outside of a host for extended periods [Thompson, 2007]. 
1.1.2 Character & Morphology 
E. coli is a Gram-negative, facultative anaerobic, typically rod shaped bacterium which does 
not sporulate. Cells are about 2.0 micrometers (μm) long and 0.25–1.0 μm in diameter. 
Motile strains possess flagella in a peritrichous arrangement. 
Table 1: Escherichia coli Classification  
Domain Bacteria 
Kingdom Bacteria 
Phylum Proteobacteria 
Class Gamma Proteobacteria 
Order Enterobacteriales 
Family Enterobacteriaceae 
Genus Escherichia 
Species Escherichia coli (E. coli) 
 
Domain and Kingdom: Escherichia coli fits into the domain and kingdom 
of Bacteriabecause members of this group are unicellular microorganisms [Moder, 2008]. 
Phylum: Escherichia coli fits into the phylum Proteobacteria because members of this group 
are Gram-negative bacterium with an outer membrane composed primarily of 
lipopolysaccharides [Moder, 2008]. 
Class: Escherichia coli fits into the class Gamma Proteobacteria because members of this 
group are facultatively anaerobic Gram-negative bacterium [Moder, 2008]. 
Order: Escherichia coli fits into the order Enterobacteriales because members of this group 
are rod-shaped facultatively anaerobic Gram-negative bacterium [Moder, 2008]. 
Family: Escherichia coli fits into the family Enterobacteriaceae because members of this 
group are motile via peritrichous flagella that grows well at 37oC, is oxidase negative, 
catalase positive and reduces nitrates [Moder, 2008]. 
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Genus: Escherichia coli fits into the genus Escherichia because members of this group are 
mostly opportunistic floras that are enteric (colonize in the intestinal tract of mammals) 
[Moder, 2008]. 
Species: Escherichia coli is one of the five species, recognized under the genus Escherichia.  
What makes E. coli unique is by these biochemical activities: ferments lactose, possesses 
lysine decarboxylase, is Vogus-Proskauer negative, produces indole, does not grow on 
nitrate, and doesnot produce H2S [Moder, 2008]. 
1.1.3 Metabolism  
E. coli is a heterotrophic organism which means the bacterium can live on a wide variety of 
substrates and uses mixed-acid fermentation in anaerobic conditions. The necessary carbon of 
the bacterium comes mainly from the host glucose which is broken down into carbon by 
means of central metabolism, a procedure consisting of three steps: 
1. Embden-Meyerhof-Parnas (EMP) Pathway 
2. Tricarboxylic Acid (TCA) cycle 
3. Pentose Phosphate Cycle (PPP) 
E. coli can synthesize carbon from also gluconate with the help of enzymes of the Entner-
Doudoroff Pathway but the bacterium does not use the pathway directly. This alternative 
pathway differs from the EMP in that the pyruvate from gluconate is converted into carbon-
dioxide andacetaldehyde. The acetaldehyde is then converted into ethanol. The pyruvate from 
EMP can be converted into ATP by E. coli, since sufficient amount of ATP is required to 
carry out metabolic processes [Gottschalk, 1979]. During these metabolic processes, the 
bacterium produces lactate, succinate, ethanol, acetate, and carbon dioxide. Since many 
pathways in mixed-acid fermentation produce hydrogen gas, these pathways require the 
levels of hydrogen to be low, as is the case when E. coli lives together with hydrogen-
consuming organisms, such as methanogens or sulphate-reducing bacteria [Madigan & 
Martinko, 2006]. 
1.1.4 Habitat 
Escherichia coli cycles between two principal habitats. The bacteria start its life in the 
intestines of warm-blooded animals and spend most of the time there. Then after excreted 
into the environment, they spend the rest of their life in water, sediment, and soil-that are 
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shown to be quite distinct with respect to physical conditions and the spectrum and level of 
available nutrients. The next stage of the cycle could be death or with a small probability, 
colonizing a new host [Savageau, 1983].The gram-negative species Escherichia coli spend a 
good part of their lives as residents of animal hosts they are most commonly known as a 
commensal of the lower intestine of mammals, although pathogenic variants also exist 
[Puente & Finlay, 2001]. The animal host is believed to be the primary habitat of this enteric 
species, which are genetically endowed to do well in this environment [Savageau, 1998]. 
The E. coli genome encodes proteins that mediate resistance to acid pH as well as growth on 
lactose, which is critical for a commensal of mammals [Blattner et al., 1997 and Lawrence & 
Ochman, 1998]. Once excreted from an animal host E. coli starts battling for survival, facing 
limited nutrient availability, osmotic stress, large variations in temperature and pH, and 
predation. From this, it can be predicted that E. coli will have at least two phenotypically 
distinct cell types and that these will have dual molecular control mechanisms of opposite 
type for the regulation of certain functions [Savageau, 1983]. 
1.2 Types of E. coli 
A huge part of the bacterial population is of E. coli since it is diverse both genetically and 
phenotypically. The diversity can be proved by the fact that only 20% genes of the typical E. 
coli genome are shared among all the strains [Lukjancenko, 2010]. The differences at 
molecular level have the ability to make changes at characteristic level such as, lifecycle or 
physiology. 
Serotype is a subdivision system of bacteria based on major surface antigens. In case of E. 
coli, the antigens are: 
 O antigen: The outer membrane of an E. coli cell contains millions of 
lipopolysaccharide (LPS) molecules, which consists of –  
1. O antigen - a polymer of immunogenic repeating oligosaccharides (1–40 units) 
2. Core region - phosphorylated nonrepeating oligosaccharides 
3. Lipid A (endotoxin) 
O antigen is encoded by the rfb gene cluster. 
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 K antigen: A thick, mucous-like, layer of polysaccharide that surrounds some 
pathogen E. coli, known as acidic capsular polysaccharide (CPS). There are two 
separate groups of K antigen, I and II. Group I is associated with capsular 
polysaccharides and II with extraintestinal diseases [Brenner et al., 2005]. 
 H antigen: The H antigen is flagellin, of the flagella that allow E. coli to move. The H 
antigen group starts from H1 to H56 with some exceptions. These are encoded by the 
fliC gene [Abbadi & Strockbine, 2007]. 
E. coli needs only to acquire a combination of mobile genetic elements to become a highly 
adapted pathogen capable of causing a range of diseases, from gastroenteritis to 
extraintestinal infections of the urinary tract, bloodstream and central nervous 
system. Hundreds of millions of people are affected annually with these diseases. Eight E. 
coli pathovars have been well characterized, and each uses varieties of virulence factors to 
weaken host immunity [Croxen & Finlay, 2013]. These pathovars are grouped into two large 
groups; diarrhoeagenic E. coli and extraintestinal E. coli. Enteropathogenic E. coli (EPEC), 
entero-haemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli 
(EIEC; including Shigella), enteroaggregative E. coli (EAEC), and diffusely adherent E. coli 
(DAEC) are diarrhoeagenic. And the other two pathovars uropathogenic E. coli (UPEC) and 
neonatal meningitis E. coli (NMEC) are extraintestinal E. coli (ExPEC) [Croxen, & Finlay, 
2013]. 
i) Enteropathogenic E. coli (EPEC):  The first pathotype described was EPEC which is 
primarily associated with causing diarrhea in children in developing countries. Pathogenesis 
of EPEC involves a plasmid-encoded protein known as EPEC adherence factor (EAF). This 
factor enables localized adherence of bacteria to intestinal cells. A non fimbrial adhesion 
called intimin, which is an outer membrane protein, mediates the final stages of adherence. 
The pathotype does not produce ST or LT toxins. Adherence procedure is very complicated 
and has dramatic effects in the structure of the cells which results in rearrangements of actin. 
The phenomenon is sometimes called "attachment and effacing" of cells. EPEC strains are 
not as invasive as Shigella, and unlike ETEC or EAEC, they cause an inflammatory response. 
The diarrhea and other symptoms of EPEC infections probably are caused by bacterial 
invasion of host cells and interference with normal cellular signal transduction, rather than by 
production of toxins [Todar, 2008]. 
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ii) Entero-haemorrhagic E. coli (EHEC): This pathotype was first recognized in 1982 which 
can cause bloody diarrhea. The main reservoir is known to be cow intestine. The primary 
cause of hemorrhagic colitis (HC) (bloody diarrhea) which can progress to potentially fatal 
hemolytic uremic syndrome (HUS) is EHEC. The bacteria are transmitted to humans through 
contaminated foods like undercooked ground beef, cold sandwiches, vegetables, water and 
other unpasteurized drinks like raw milk, apple juice. The pathogen colonizes the intestinal 
area including the distal ileum and large bowels of human body. EHEC are characterized by 
the production of verotoxin or Shiga toxins (Stx) [Todar, 2008]. There are many serotypes of 
Stx-producing E. coli but only those that have been clinically associated with HC are 
designated as EHEC. Of these, O157:H7 is the prototypic EHEC and most often causes 
illness worldwide [Todar, 2008]. EHEC are considered to be "moderately invasive". Nothing 
is known about the colonization antigens of EHEC but fimbriae are presumed to be involved. 
The bacteria do not invade mucosal cells as readily as Shigella, but EHEC strains produce a 
toxin that is virtually identical to the Shiga toxin. The toxin plays a role in the intense 
inflammatory response produced by EHEC strains and may explain the ability of EHEC 
strains to cause HUS. The toxin is phage encoded and its production is enhanced by iron 
deficiency [Griffin & Tauxe, 1995; Todar, 2008]. 
iii) Enterotoxigenic E. coli (ETEC): ETEC is the disease commonly referred to as traveler's 
diarrhea. ETEC causes diarrhea in children in developing countries and is the main cause of 
diarrhea in travelers to developing countries. Transmission occurs through water and foods 
like soft cheese, raw vegetables etc. The diseases vary from minor discomfort to a severe 
cholera-like syndrome. The disease requires colonization and elaboration of one or more 
enterotoxins. Both traits are plasmid-encoded. ETEC may produce a heat-labile enterotoxin 
(LT) that is similar in molecular size, sequence, antigenicity, and function to the cholera toxin 
(Ctx). It binds to the same identical ganglioside receptors that are recognized by the cholera 
toxin (i.e., GM1) and its enzymatic activity is identical to that of the cholera toxin. ETEC 
may also produce a heat stable toxin (ST) that is of low molecular size and resistant to boiling 
for 30 minutes. Their small size explains why they are not inactivated by heat.  
ETEC have species specific fimbriaes which act as adhesins. These fimbrial adhesins adhere 
to specific receptors on enterocytes of the proximal small intestine. Symptoms of infection 
include diarrhea without fever. The bacteria colonize the GI tract by means of a fimbrial 
adhesion and are noninvasive, but produce either the LT or ST toxin [Todar, 2008]. 
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iv) Enteroinvasive E. coli (EIEC): There are no known animal reservoirs of EIEC. So the primary 
source for EIEC appears to be infected humans. EIEC are non-motile. Pathogenicity is primarily 
due the ability to invade and destroy colonic tissue. EIEC closely resemble Shigella in their 
pathogenic mechanisms and the kind of clinical illness they produce. EIEC penetrate and 
multiply within epithelial cells of the colon causing widespread cell destruction. The clinical 
syndrome is identical to Shigella dysentery and includes a dysentery-like diarrhea with fever. 
EIEC apparently lack fimbrial adhesins but do possess a specific adhesion outer membrane 
protein. EIEC are invasive organisms. They do not produce LT or ST toxin [Wellington & Van 
Elsas, 1992; Todar, 2008]. 
 
v) Enteroaggregative E. coli (EAEC): EAEC strains have the ability to attach to tissue culture 
cells in an aggregative manner. These strains are associated with persistent diarrhea in young 
children. They resemble ETEC strains in that the bacteria adhere to the intestinal mucosa and 
cause non-bloody diarrhea without invading or causing inflammation. This suggests that the 
organisms produce an enterotoxin of some sort. Recently, a distinctive heat-labile plasmid-
encoded toxin has been isolated from these strains, called the EAST (Entero Aggregative ST) 
toxin. They also produce a hemolysin. The role of the toxin and the hemolysin in virulence has 
not been proven. The significance of EAEC strains in human disease is controversial [Wellington 
& Van Elsas, 1992; Todar, 2008]. 
 
vi) Diffusely adherent E. coli (DAEC): Some types of EPEC are referred to as diffusely adherent 
E. coli (DAEC), based on specific patterns of adherence. They are an important cause of traveler's 
diarrhea in Mexico and in North Africa [Todar, 2008]. DAEC strains are significantly 
associated with diarrhea in children and urinary tract infections in adults [Servin et al., 2005]. 
The strains are heterogeneous with respect to plasmid content and serotype [Girón et al., 
1991]. They generate a diffuse adherence pattern on HeLa and HEp-2 cells. This pattern is 
mediated by proteins encoded by a family of related operons, which includes both fimbrial and 
afimbrial adhesins, collectively designated Afa–Dradhesions. [Servin et al., 2005] 
 
vii) Uropathogenic E. coli (UPEC): Strains of UPEC are the primary cause of urinary tract 
infections, including both cystitis and pyelonephritis. These bacteria have evolved a 
multitude of virulence factors and strategies that aid in bacterial growth and persistence 
within the environment of host’s urinary tract. Expression of adhesins like type 1 and P pili 
allow UPEC to bind and invade host cells and tissues within the urinary tract. Hemolysin and 
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cytotoxic necrotizing factor 1 help UPEC cause extensive tissue damage, bacterial 
dissemination as well as releasing host nutrients and disabling immune effector cells. These 
toxins also have the capacity to alter inflammatory responses, host cell survival, and 
cytoskeletal dynamics [Wiles et al., 2008]. 
viii) Neonatal meningitis E. coli (NMEC):  Most cases of E. coli meningitis occur in 
newborns. It may also occur in people who have a CSF shunt or have head injuries and head 
surgeries. In a study, 84% of E. coli from the cerebrospinal fluid of neonates with meningitis 
had capsular (K1) polysaccharide. The K1 capsular antigen has been shown to be 
immunochemically identical to the meningococcal Group B polysaccharide. The high 
prevalence of the K1 antigen in neonatal meningitis suggests that this capsular polysaccharide 
is related to E. coli invasiveness in the newborn [Robbins et al., 1974]. 
1.3 Pathogenesis of E. coli 
Since there are over 700 serotypes of E. coli, the probability of a strain being pathogenic is 
high. There are several highly adapted E. coli strains that have acquired specific virulence 
attributes. These strains are able to adapt to new niches which allows them to cause a broad 
spectrum of disease. These virulence attributes are frequently encoded on genetic elements 
[Kaper et al., 2004] and generally associated with the three antigens of the bacterium; the O 
antigen derived from the cell wall, H antigen derived from flagella and the secreting K 
antigen derived from a polysaccharide capsule. Three general clinical syndromes can result 
from infection with the pathogenic E. coli: enteric/diarrheal disease, urinary tract infections 
(UTIs) and sepsis/meningitis [Kaper et al., 2004]. Pathogenic E. coli strains follow a multi-
step process to infect a host body. Generally the steps that are followed are similar to that of 
other mucosal pathogens: colonization of a mucosal site, evasion of host defenses, 
multiplication and host damage. 
1.3.1 Enteric/Diarrheal Diseases 
E. coli typically colonizes the gastrointestinal tract of human to coexist in good health. Since 
the bacteria are adapted to survive in the gastrointestinal tract, the pathogens are able to infect 
the intestines easily, resulting in diarrhea. The types of diarrhea are further categorized based 
on the six subgroups, ETEC, EIEC, EHEC, EPEC, EHEC and DAEC.  
The six recognized categories of diarrhoeagenic E. coli each have unique features in their 
interaction with eukaryotic cells.  
9 | P a g e  
Introduction 
 EPEC adhere to small bowel enterocytes, but destroy the normal microvillar 
architecture, inducing the characteristic attaching and effacing lesion. Cytoskeletal 
derangements are accompanied by an inflammatory response and diarrhoea [Kaper et 
al., 2004]. A recent study showed that EPEC can disrupt cell polarity [Muza-Moons et 
al., 2003]. 
 EHEC also induce the attaching and effacing lesion, but in the colon. The 
distinguishing feature of EHEC is the elaboration of Shiga toxin (Stx), systemic 
absorption of which leads to potentially life-threatening complications [Kaper et al., 
2004]. 
 ETEC adhere to small bowel enterocytes and induce watery diarrhoea by the secretion 
of heat-labile (LT) and/or heat-stable (ST) enterotoxins [Kaper et al., 2004]. 
 EAEC adheres to small and large bowel epithelia in a thick biofilm and involves 
secretory enterotoxins and cytotoxins [Kaper et al., 2004]. 
 EIEC invades the colonic epithelial cell, lyses the phagosome and moves through the 
cell by nucleating actin microfilaments. The bacteria either move laterally through the 
epithelium by direct cell-to-cell spread or exit and re-enter the plasma membrane 
[Kaper et al., 2004]. 
 DAEC elicits a characteristic signal transduction effect in small bowel enterocytes 
that manifests as the growth of long finger-like cellular projections, which wrap 
around the bacteria [Kaper et al., 2004]. 
1.3.2 Urinary Tract Infections 
90% of UTI cases are caused by Uropathogenic E. coli [Moder, 2008]. This results from the 
pathogenic E. coli strains having specific adherence factors which aid them in adhering and 
colonizing sites that E. coli generally does not colonize. UPEC causes urinary tract infections 
upon infecting the urethra, an unlikely region to be infected with the organism. The pathogen 
has the ability to adhere and colonize the urethra and bladder with the help of adhesins like 
fimbriae. Finally inflammation of the bladder results in infection [Moder, 2008]. 
1.3.3 Sepsis/ Meningitis  
This type of E. coli is the most common cause of Gram negative neonatal meningitis, with a 
case fatality rate of 15–40% and severe neurological defects in many of the survivors 
[Unhanand et al., 1993; Dawson et al., 1999]. E. coli that cause meningitis are spread 
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haematogenously. The bacteria enter through the gastrointestinal tract or nasopharynx into 
blood. Blood then carries the bacteria to the central nervous system without any damage to 
the blood brain barrier. If not treated, this infection may result into death [Moder, 2008]. 
1.4 Virulence Factors 
The diseases caused by a particular strain of E. coli depend on distribution and expression of 
an array of virulence determinants, including adhesins, invasins, toxins, and abilities to 
withstand host defenses.  
1.4.1 Adhesins 
Adhesins allow the pathogenic E. coli to adhere to sites that they do not normally inhabit, like 
small intestine and urethra. Most frequently these adhesins form distinct morphological 
structures called fimbriae (also called pili) or fibrillae, which can belong to one of several 
different classes. Fimbriae are rod-like structures of 5–10 nm in diameter that are distinct 
from flagella. Fibrillae are 2–4 nm in diameter and are either long and wiry or curly 
andflexible [Cassels & Wolf, 1995]. The Afa adhesins that are produced by many 
diarrhoeagenic and uropathogenic E. coli are described as a fimbrial adhesins but in fact seem 
to have a fine fibrillar structure that is difficult to visualize [Keller et al., 2002]. Adhesins of 
pathogenic E. coli can also include outer-membrane proteins, such as intimin of UPEC and 
EHEC, or other non-fimbrial proteins. Some surface structures trigger signal transduction 
pathways or cytoskeletal rearrangements that can lead to disease. Surface structures that are 
present on commensal E. coli strains can induce signalling cascades if the organism 
encounters the appropriate receptor. The LPS of E. coli and other Gram-negative bacteria 
binds to Toll-like receptor 4 (TLR4), triggering a potent cytokine cascade that can lead to 
septic shock and death [Tapping et al., 2000]. Flagellin, the main component of flagella, can 
bind to TLR5, thereby activating interleukin (IL)-8 expression and an inflammatory response 
[Hayashi et al., 2001]. 
1.4.2 Invasins 
Invasins help the pathogens to invade the host immunity system thus eliminating the barrier 
that is keeping them from infecting the host. Hemolysin is such an invasin. Shigella like 
invasins are utilized for intracellular invasion and spreading [Todar, 2008]. 
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1.4.3 Toxins 
Secreted toxins and other effector proteins are present in greater numbers which trigger signal 
transduction pathways and affect variety of eukaryotic processes. Different strains of EPEC 
produce 3 different toxins, the heat-labile enterotoxin (LT), heat-stable enterotoxin a (STa) 
and heat-stable enterotoxin b (STb) which helps in ion secretion [Kaper et al., 2004]. The 
Shiga toxin (Stx) of EHEC cleaves ribosomal RNA, thereby disrupting protein synthesis and 
killing the intoxicated epithelial or endothelial cells [Melton-Celsa & O’Brien, 1998]. The 
cytolethal distending toxin (CDT) has the ability to block cell division. [De Rycke & Oswald, 
2001]  Another toxin that blocks cell division is called Cif (cycle-inhibiting factor) [Marches 
et al., 2003]. The cytotoxic nectrotizing factors (CNF 1 and CNF 2) deaminate a crucial 
glutamine residue of RhoA, Cdc42 and Rac, thereby locking these important signalling 
molecules in the ‘on’ position and leading to marked cytoskeletal alterations, multinucleation 
with cellular enlargement, and necrosis [Lerm et al., 1999]. The Map protein of EPEC and 
EHEC stimulates filopodia formation and targets mitochondria to disrupt membrane potential 
in these organelles [Kenny et al., 2002]. 
1.4.4 Plasmids 
There are now numerous examples of plasmids that encode crucial virulence factors of 
pathogenic E. coli, including plasmids in EAEC that encode fimbriae and toxins, plasmids in 
EIEC/Shigella that encode a type III secretion system and invasion factors. There are also R 
factors and drug resistance plasmids. Although many of these plasmids are self-transmissible, 
some lack conjugation genes and can only be transferred with a conjugative plasmid. For 
ETEC, the genes that encode both LT and ST are found on plasmids, but some estA genes 
encoding STa are on transposons that can be inserted into either plasmids or the chromosome 
[McVeigh et al., 2000]. 
1.4.5 Others 
K antigen, LPS and capsules have other properties like, antiphagocytic, defense mechanism 
against antibactericidal reactions and defense against immune responses. Flagella aid in 
motility and chemotaxis [Todar, 2008]. 
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1.5 Transmission 
Most intestinal infections are caused by contaminated food or water, when a person eats food, 
or drinks water or ice contaminated with the pathogen. Human or animal wastes (e.g., feces) 
are the ultimate source of contamination. Animals, mostly cattle play as reservoirs of the 
pathogens. The high prevalence of E. coli O157 and non-O157 STEC in some cattle 
populations, combined with the lack of effective on-farm control strategies to reduce carriage, 
represents a significant risk of contamination of the food supply and the environment.  Non-
O157 STEC are also harbored in other ruminants, including swine [Fratamico, 
2007]. Pathogenic E. coli are believed to mostly live in the intestines of cattle, but these 
bacteria have also been found in the intestines of chickens, deer, sheep etc. If the infected 
meat is not cooked to 160°F (71°C), the bacteria can survive and infect after consumption of 
the contaminated meat. This is the most common way people in the United States become 
infected with E. coli. Any food that has been in contact with raw meat can also become 
infected. Other food products that can be contaminated with E. coli includes, raw milk or 
other dairy products which comes in contact with the pathogen from cow’s udder. And also 
raw fruits and vegetables such as lettuce, alfalfa sprouts, or unpasteurized apple cider or other 
unpasteurized juices that have come in contact with infected animal feces [WebMD, 2014]. 
When water supply of a city/town is contaminated with human or animal feces, people get 
infected if not properly treated with chlorine. E. coli also spread from one person to another, 
when an infected person does not maintain hygiene, after a bowel movement. E. coli can 
spread from an infected person's hands to other people or through fomites [WebMD, 2014] 
1.6 E. coli related Diseases 
Escherichia coli is one of the most frequent causes of many common bacterial infections, 
including urinary tract infection (UTI), traveler's diarrhea, 
cholecystitis, bacteremia, cholangitis and other clinical infections such as neonatal 
meningitis and pneumonia [Madappa, 2015]. 
1.6.1 Enteric infections 
Six different pathotypes of E. coli cause enteric infections by following six different 
mechanisms. ETEC is a cause of traveler's diarrhea resulting in watery diarrhea and 
abdominal cramping. EPEC causes childhood diarrhea. EIEC causes a Shigella -like 
dysentery. EHEC causes hemorrhagic colitis or hemolytic-uremic syndrome which is a type 
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of kidney failure. EAEC is primarily associated with persistent diarrhea in children in 
developing countries, and DAEC is a cause of childhood diarrhea and traveler's diarrhea in 
Mexico and North Africa. ETEC, EPEC, EAEC, and DAEC colonize the small bowel, and 
EIEC and EHEC preferentially colonize the large bowel prior to causing diarrhea [Madappa, 
2015]. 
Shiga toxin–producing E. coli (STEC) is among the most common causes of food borne 
diseases. This organism is responsible for several gastrointestinal tract illnesses, including 
non bloody and bloody diarrhea. Patients with these diseases, especially children, may be 
affected by neurologic and renal complications, including HUS. Strains of STEC serotype 
O157-H7 have caused numerous outbreaks and sporadic cases of bloody diarrhea and HUS 
[Madappa, 2015]. In addition to E. coli O157, many other non-O157 STECs also cause 
disease. Some non-O157 STECs cause disease that is often severe, resulting in bloody 
diarrhea and sometimes HUS [CDC, 2014].  People with weakened immune systems, 
pregnant women, young children, and older adults are at increased risk for developing these 
complications. 
1.6.1.1 Symptoms of Enteric Infections 
Symptoms of intestinal infection generally begin between one and five days after being 
exposed to E. coli and can last from a few days to more than a week. Symptoms include: 
 Abdominal cramping 
 Sudden, severe watery diarrhea that may change to bloody stools 
 Gas 
 Loss of appetite/nausea 
 Vomiting (uncommon) 
 Fatigue 
 Fever [Pietrangelo, 2015]. 
Symptoms of a severe E. coli infection may include: 
 Bloody urine 
 Decreased urine output 
 Pale skin 
 Bruising 
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 Dehydration [Pietrangelo, 2015]. 
1.6.2 Urinary tract infections 
The urinary tract is the most common site of E coli infection, and more than 90% of all 
uncomplicated UTIs are caused by E. coli infection. The recurrence rate after a first E. 
coli infection is 44% over 12 months. E coli UTIs are caused by uropathogenic strains of E. 
coli. E. coli causes a wide range of UTIs, including uncomplicated urethritis/cystitis, 
symptomatic cystitis, pyelonephritis, acute prostatitis, prostatic abscess, and urosepsis. 
Uncomplicated cystitis occurs primarily in females who are sexually active and are colonized 
by auropathogenic strain of E. coli. Subsequently, the periurethral region is colonized from 
contamination of the colon, and the organism reaches the bladder during sexual intercourse 
[Madappa, 2015]. 
Complicated UTI and pyelonephritis are observed in elderly patients with structural 
abnormalities or obstruction such as prostatic hypertrophy orneurogenic bladders or in 
patients with urinary catheters. E. coli bacteremia is usually associated with UTIs, especially 
in cases of urinary tract obstruction of any cause. The systemic reaction to endotoxin 
(cytokines) or lipopolysaccharides can lead to disseminated intravascular coagulation and 
death. E. coli is a leading cause of nosocomial bacteremia from a GI or genitourinary source 
[Madappa, 2015]. 
1.6.2.1 Symptoms of UTI  
Urinary tract infections do not always cause signs and symptoms, but when they do they may 
include: 
 A strong, persistent urge to urinate 
 A burning sensation when urinating 
 Passing frequent, small amounts of urine 
 Unusual-smelling, cloudy, or bloody urine 
 Fever or chills 
 Pelvic pain in women, rectal pain in men [Mayo Foundation for Medical Education 
and Research, 2015]. 
 
15 | P a g e  
Introduction 
1.6.3 Acute Bacterial Meningitis 
 
The vast majority of neonatal meningitis cases are caused by E. coli and group B 
streptococcal infections (28.5% and 34.1% overall, respectively). Pregnant women are at a 
higher risk of colonization with the K1 capsular antigen strain of E coli. This strain is also 
commonly observed in neonatal sepsis, which carries a mortality rate of 8%; most survivors 
have subsequent neurologic or developmental abnormalities. Low birth weight and a positive 
cerebrospinal fluid (CSF) culture result foretell a poor outcome. In adults, E. coli 
meningitis is rare but may occur following neurosurgical trauma or procedures [Madappa, 
2015]. 
1.6.3.1 Symptoms of Bacterial Meningitis 
A strain of E. coli called K1 causes about 20 percent of all cases of neonatal meningitis, 
according the Meningitis Research Foundation. Newborns may become infected with E. 
coli K1 during birth, or from bacteria later acquired in the hospital or home. Symptoms 
include:  
 Irritability 
 Breathing trouble 
 Diarrhea 
 Unusually cold or warm skin 
 Fussy feeding 
 Lethargy or inactivity 
 Bulging soft spot at the top of the head (the fontanelle) 
 Nausea [Everyday Health, 2014]. 
1.6.5 Intra-Abdominal Infections 
E. coli intra-abdominal infections often result from a perforated viscus (eg, appendix) or may 
be associated with intra-abdominal abscess, cholecystitis, and ascending cholangitis. Patients 
with diabetes mellitus are also at high risk of developing pylephlebitis of the portal vein 
and liver abscesses. Intra-abdominal abscesses are usually polymicrobial, E. coli is one of the 
more common gram-negative bacilli observed together with anaerobes. Abscesses can be 
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caused by GI tract perforation or after anastomotic disruption with spillage of colon contents 
[Madappa, 2015]. 
Cholecystitis and cholangitis result from obstruction of the biliary system from biliary stone 
or sludge. This leads to stagnation and bacterial growth from circulation. When bile flow is 
obstructed, colonic organisms, including E. coli, colonize the jejunum and 
duodenum [Madappa, 2015]. 
1.6.6 Other Infections 
Other E. coli infections include septic arthritis, endophthalmitis, suppurative thyroiditis, 
sinusitis, osteomyelitis, endocarditis, and skin and soft-tissue infections (especially in patients 
with diabetes) [Madappa, 2015].  
1.7 Immune Response to E. coli 
The innate immune system triggers inflammation accompanied by inflammatory cytokine 
secretion, neutrophil recruitment and massive tissue destruction in reponse to E. coli invasion 
and replication within host cells [Ashida et al., 2015]. Apart from white blood cells which act 
as the first defenders of the immune system and the other members of the phagocyte family, 
the complement system plays an important role in host defense against Gram-negative 
bacterial infection, including E. coli infection. The system consists of at least 30 proteins that 
orchestrate attack on pathogenic agents. Although the susceptibility of Gram-negative 
bacteria to complement attack has been under investigation for over 100 years, the 
mechanism(s) by which the complement directly kills Gram-negative bacteria (E. coli) is not 
understood [Bloch et al., 2011]. 
The complement system consists of three pathways: Classical, Alternative and Lectin 
pathway, each having their own unique method of activation. Activation of complement by 
gram-negative bacteria including E. coli can occur via the classical or the alternative 
pathway; the former usually requires for its activation recognition of bacterial surface 
antigens by certain antibody classes, whereas activation of the latter can be initiated and 
amplified, in the absence of antigen-antibody interactions, by poorly understood structural or 
conformational characteristics of the cell surface [Taylor, 1983]. Activation of each pathway 
results in the production of a macro molecular structure called the membrane attack complex 
(MAC) which consists of terminal or late acting complement proteins (C5b-9 complexes). 
The C5b-9 complexes are needed for direct killing of Gram-negative bacteria. However, the 
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exact mechanism(s) by which inner membrane damage to Gram-negative bacteria by C5b-9 
complexes leads to cell death is not known [Bloch et al., 2011]. Opsonization is another 
immune process that targets E. coli for destruction, using phagocytes and opsonins which 
enhance the phagocytosis.   
In addition to complement, lysozyme, calcium (Ca2+) and magnesium (Mg2+) are important 
components of extracellular fluids that are required for killing Gram-negative bacteria. 
Calcium and magnesium ions are essential for initiation of the classical complement 
sequence. Other factors such as antitoxins, antiviral antibodies, opsonins (C3b/ antibodies) 
and antilysins, play a role in the bactericidal activity of human serum [Igumbor & Osayande, 
2000]. 
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the 
National Institutes of Health, have shown how the O157:H7 strain of Escherichia coli causes 
infection and thrives by manipulating the host immune response. The bacterium secretes a 
protein called NleH1 that directs the host immune enzyme IKK-beta to alter specific immune 
responses. This process not only helps the bacterium evade elimination by the immune 
system, it also works to prolong the survival of the infected host, enabling the bacterium to 
persist and ultimately spread to unaffected individuals [Wan et al., 2011]. Although the 
systemic and local immune response to the O antigen of Escherichia coli has been well 
characterized, little information is available on the immune response to K antigen. while the 
K antigen of Escherichia coli functions as a virulence factor in upper urinary tract infections, 
this antigen does not elicit a significant immune response, whereas the O antigen does induce 
a significant antibody response which could be of protective or diagnostic benefit [Smith & 
Kaijser, 1976]. 
1.8 Outbreaks  
1.8.1 Jack in the Box E. coli outbreak, 1993 
The outbreak was in the western U.S. that began in late 1992, and lasted into 1993. It was 
linked to the consumption of hamburgers served by the Jack in the Box Restaurant chain. 732 
people were infected with the Escherichia coli O157:H7 bacterium [Nestle, 2010; South 
Wales Echo, (Cardiff), 2008; Schlosser, 2001]. Investigation revealed that restaurant outlets 
were serving contaminated beef and were not cooking the hamburgers thoroughly. Seventy-
three Jack in the Box restaurants were ultimately identified as part of the outbreak. Cases 
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were reported from Washington (602 cases/144 hospitalizations/3 deaths), Idaho (14 cases/4 
hospitalizations/no deaths), California (34 cases/14 hospitalizations/1 death), and Nevada (58 
cases/9 hospitalizations/no deaths) [MarlerClark, 2015]. The outbreak has been described as 
"far and away the most infamous food poison outbreak in contemporary history [Golan et al., 
2004; Hanlon, 2001; Denn, 2011]. The majority of the victims were children aged under 10-
years old [Hunter, 2009; Schlosser & Wilson, 2006]. Four children died and 178 other 
victims were left with permanent injury including kidney and brain damage [Rogers, 1995; 
Sylvester, 1995]. 
1.8.2 Germany E. coli O104:H4 outbreak, 2011 
A devastating E. coli O104:H4 outbreak in Northern Germany occurred in May through June 
in 2011. It was eventually attributed to the consumption of fenugreek sprouts grown at a farm 
in Germany. Primary cases were associated with sprout consumption; secondary transmission 
was also documented. The E. coli outbreak resulted in more than 3950 cases, an unknown 
number of hospitalizations and 53 deaths [European Food Safety Authority, 2012]. The 
illness was characterized by bloody diarrhea, with a high frequency of serious complications, 
including hemolytic-uremic syndrome (HUS). Cases were reported throughout the European 
Union and the United States [MarlerClark, 2015]. Epidemiological fieldwork suggested fresh 
vegetables were the source of infection. An organic farm in Bienenbüttel, Lower Saxony, 
Germany which produces a variety of sprouted foods was identified as the likely source of 
the E. coli outbreak. The farm was shut down [CNN, 2010]. On 30 June 2011, the German 
Bundesinstitut für Risikobewertung (BfR) (Federal Institute for Risk Assessment), an 
institute of the German Federal Ministry of Food, Agriculture and Consumer Protection, 
announced that seeds of fenugreek imported from Egypt were likely the source of the 
outbreak [Bundesinstitut für Risikobewertung (BfR), 2011]. 
1.9 E. coli in Bangladesh 
1.9.1 Overall Condition 
Acute infectious diarrhea (AID) is a major cause of morbidity and mortality worldwide, and 
it remains a major public health challenge especially in developing countries where it is a 
leading cause of death [Kabir, 2011]. Every year nearly 1.4 billion episodes of AID occur in 
children less than 5 years of age in developing countries [Kosek et al., 2003; Parashar et al., 
2003] diarrheal illness account for an estimated 12600 deaths each day in children under 5 
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years of age in Asia, Africa and Latin America [Nguyen et al., 2005]. Numerous studies 
performed in different countries have reported diarrheagenic Escherichia coli pathotypes as 
being the most frequent and important among bacterial pathogens associated with AID in 
developing countries. However, the frequencies of these pathogens vary with geographic 
region and depend on the socioeconomic/sanitary conditions achieved [Black, 2010; O'Ryan 
et al., 2010]. In Bangladesh, the AID remains one of the most important health problems 
surpassed only by the respiratory diseases. One third of the total child death burden is due to 
diarrhea. Every year, a rural child suffers on average from 4.6 episodes of diarrhea, from 
which about 230,000 children die [Piechulek et al., 2003]. Diarrheagenic Escherichia coli has 
been reported to be responsible for 34% of diarrheal episodes in Bangladesh [ICDDR, B 
2002]. 
1.9.2 E. coli Related Studies in Bangladesh  
1.9.2.1 Controlled study of Escherichia coli diarrheal infections in Bangladeshi children 
The relative contribution of diarrheagenic Escherichia coli organisms to diarrhea in 
Bangladeshi populations is not known. Albert and his group analyzed fecal E. coli from 451 
children up to 5 years of age with acute diarrhea seeking treatment at a Dhaka hospital and 
from 602 matched control children without diarrhea from July 1991 to May 1992.The results 
showed that ETEC was significantly associated with diarrhea in the diarrheal children as a 
whole and especially in the age groups of 0 to 24 months and 37 to 48 months. EPEC was 
significantly associated with diarrhea in the diarrhea group as a whole and particularly in 
infants up to 1 year of age. Their overall data thus suggest that EPEC and ETEC are 
important causes of acute diarrhea in children in this setting [Albert et al., 1995]. 
1.10 Antimicrobial Agents for E. coli 
Antimicrobial drugs have played an indispensable role in decreasing illness and death 
associated with infectious diseases in animals and humans [Aarestrup et al., 2008]. A wide 
range of antimicrobial agents effectively inhibit the growth of E. coli. The β-lactams, 
fluoroquinolones, aminoglycosides and trimethoprim-sulfamethoxazole are often used to treat 
community and hospital infections due to E. coli [Pitout, 2012]. β-lactams disrupt cell wall 
synthesis by binding to and inhibiting the penicillin-binding proteins essential for 
transpeptidation and carboxypeptidation reactions in cell wall peptidoglycan synthesis. 
Fluoroquinolones interfere with DNA supercoiling and promote DNA gyrase-mediated 
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double-stranded DNA. The aminoglycosides bind irreversibly to the 50S subunit of the 70S 
bacterial ribosomes. Sulfonamides and trimethoprim interfere with bacterial folic acid 
synthesis by inhibiting tetrahydropteric acid syntheses and dihydrofolatereductase, 
respectively [Allen et al., 1998]. Silver nanoparticles were shown to be an effective 
bacteriocide. The particles accumulate in the bacterial membrane, forming pits in the cell 
wall. This increases the permeability, resulting into cell death [Sondi et al., 2003]. 
1.10.1 Antimicrobial Drug Resistance in Escherichia coli 
Selective pressure exerted by antimicrobial drug use has been the major driving force behind 
the emergence and spread of drug-resistance traits among pathogenic and commensal bacteria 
[Daniel et al., 2012]. Among E. coli, b-lactamase production remains the most important 
contributing factor to b-lactam resistance. b-lactamases are bacterial enzymes that 
inactivate b-lactam antibiotics by hydrolysis, which results in ineffective compounds. The b-
lactam antibiotics, especially the cephalosporins and b-lactam-b-lactamases inhibitor 
combinations, are major drug classes used to treat community-onset or hospital-acquired 
infections caused by E. coli, especially due to the ExPEC pathotype. Resistance to 
aminopenicillins (e.g. ampicillin) and early-generation cephalosporins (e.g. cefazolin) 
among E. coli is often mediated by the production of narrow-spectrum b-lactamases such 
as TEM-1, TEM-2 and to a lesser extent SHV-1 enzyme. Most importantly among E. coli, is 
the increasing recognition of isolates producing the so-called “newer b-lactamases” that 
causes resistance to the expanded-spectrum cephalosporins and/or the carbapenems. Plasmid-
mediated resistance mechanisms can reduce fluoroquinolone susceptibilities in E. coli. 
Resistance to aminoglycosides may develop because of impaired uptake and aminoglycoside 
phosphorylation. Trimethoprim-sulfamethoxazole resistance results from alterations of 
different substrate enzymes or their overproduction, loss of bacterial drug-binding capacity, 
and decreased cell permeability [Allen et al., 1998]. 
1.11Treatment  
Medical care of E coli infection is based on the site and severity of infection [Madappa, 
2015]. Home care is all that is required to treat an E. coli infection, in most cases. Drinking 
plenty of water for replenishing the lost water from diarrhea and vomiting, resting is having 
adequate amount of food to prevent malnutrition are very important. But for more severe 
symptoms, visiting a doctor is required. Antibiotics are not recommended because they have 
the ability to increase the risk of developing hemolytic uremic syndrome (HUS) [Wong et al. 
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2000]. Most individuals who do not develop HUS recover within two weeks [Siegler, 1995]. 
However, antibiotics and antimotility agents may be useful for other types of E. coli, such as 
enterotoxigenic E. coli, which causes traveler's diarrhea. In the absence of severe symptoms, 
such as bloody diarrhea or intense abdominal pain, some doctors believe it's acceptable to use 
antimotility medication [Benington-Castro, 2014]. In general, monotherapy with 
trimethoprim-sulfamethoxazole, aminoglycoside, cephalosporin, or a fluoroquinolones is 
recommended as the treatment of choice for most known infections with E. coli, although 
many broad spectrum agents remain highly active [Allen et al., 1998]. 
In case of HUS, if left untreated it can lead to various severe complications like skin 
problems, decreased urination and sometimes seizures. So HUS requires prompt medical 
treatment which includes, 
 IV fluid and electrolyte replacement 
 Red blood cell transfusion 
 Platelet transfusion (to help the blood clot normally) 
 Kidney dialysis  
If kidneys become permanently damaged, switching to a low-protein diet and medications 
such as angiotensin-converting enzyme (ACE) inhibitors, which lower the blood pressure, are 
treatments to help prevent further kidney damage. Long-term dialysis or a kidney transplant 
may also be needed. Doctors typically treat UTIs with a wide range of different antibiotics, 
such as ciprofloxacin (Cipro) and trimethoprim-sulfamethoxazole (Bactrim). However, some 
strains of E. coli, called extended-spectrum beta-lactamase (ESBL) E. coli, are resistant to 
most antibiotic treatments. There are now only a few classes of oral antibiotics that remain 
effective at treating UTIs from ESBL E. coli, such as fosfomycin (Monural) and 
nitrofurantoin (Macrobid) [Benington-Castro, 2014].  E. coli meningitis requires antibiotics, 
such as third-generation cephalosporins (eg, ceftriaxone). E. coli pneumonia requires 
respiratory support, adequate oxygenation, and antibiotics, such as third-generation 
cephalosporins or fluoroquinolones [Madappa, 2015]. 
1.12 Prevention 
E. coli related infections cannot be prevented with vaccines or medications. The best ways to 
reduce the chance of being exposed to the organism are to avoid risky foods and watching out 
for cross-contamination. 
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 Washing fruits and vegetables thoroughly 
 Avoiding cross-contamination by using clean utensils, pans, and serving platters 
 Keeping raw meats away from other foods and away from other clean items 
 Not defrosting meat on the counter 
 Always defrosting meat in the refrigerator or microwave 
 Refrigerating leftovers immediately 
 Drinking only pasteurized milk products (avoid raw milk) 
 Not preparing food, not swimming and bathing with others, if one has diarrhea 
 Meat should be cooked properly. The U.S. Department of Agriculture provides 
guidelines for cooking meat and poultry to proper temperatures to make sure all 
bacteria are killed. 
 poultry: 165 degrees Fahrenheit 
 ground meat, eggs: 160 degrees 
 steaks, pork chops, roasts, fish, shellfish: 145 degrees 
 
 Practicing good hygiene and following food safety guidelines can go a long way to 
prevent an E. coli infection. Washing hands before handling, serving, or eating food, 
and especially after touching animals, working in animal environments, or using the 
bathroom should be done regularly [Pietrangelo, 2015]. 
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1.14 Objective of the Study 
For being a small yet populated country, people of Bangladesh come from different 
background with different lifestyle, food habit and health condition. These factors may affect 
the immune responses of the population thus presenting varying degree of susceptibility to 
microbe mediated diseases. 
Escherichia coli are mostly harmless and an important part of a healthy human intestinal 
tract. However, some E. coli are pathogenic, causing illnesses like diarrhea, urinary tract 
infections, meningitis etc. E. coli related enteric infections have a greater prevalence in 
Bangladesh than most diseases. 34% of the diarrhea related infections are caused by the 
diarrheal E. coli in Bangladesh. People from every background are exposed to this organism 
by means of environment since E. coli is also a beneficial organism inhabiting human and 
animal guts which occasionally comes in contact with the environment through fecal 
contamination. But a certain infectious dose is required to develop an infection. When an 
individual is exposed to the bacteria, different components of blood come forward to play 
their roles. Complement, as a vital part of the body’s immune system, provides a highly 
effective means for the destruction of the invading bacteria and for immune complex 
elimination.  
As a developing country, Bangladesh still has a large portion of her people living in slums, 
below the poverty line. These people have a completely different life style from people living 
in the urban area. Their living pattern, food habit, hygienity, vaccination etc. differs from 
those who are well off. The objective of this study is to observe and compare the complement 
mediated inhibition capability of human blood serum collected from these two different 
population groups of two different standards of living against E. coli. Comparative data tables 
and charts according to the result would demonstrate the comparison which would be the 
basis of the observation from experiment where the factors will be analyzed and comparative 
complement mediated inhibition activity of blood of the two different population of 
Bangladesh would be documented. Detailed comparative studies like comparing the 
susceptibility of the people living in urban area to people living in slum, against a specific 
potential pathogen microorganism has not been done yet in Bangladesh. So this study has the 
potential to demonstrate if parameters based on life style, affect the complement activity of 
serum.  
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2. Materials and Methods 
2.1 Working place 
The laboratory works of this research study were carried out in the laboratory of 
Microbiology, of the Department of Mathematics and Natural Sciences of BRAC University. 
2.2 Bacterial Strain 
Escherichia coli strain used for this particular research work was collected from BRAC 
University Microbiology Laboratory. Subculture was prepared from the laboratory culture for 
using in research purpose. To keep the bacteria viable and to prevent contamination from 
other microorganisms, subculture was done every week. The freshly cultured colonies were 
used in the procedure.  
2.3 Identification of E. coli 
Though the bacterial strain provided by the laboratory was of E. coli, some identification tests 
were done for reconfirmation.  
2.3.1 Selective Media: One of the tests was streaking on Eosin Methylene Blue (EMB) to 
ensure the presence of E. coli as EMB acts as a selective media for this gram negative 
bacillus. 
1. A freshly prepared EMB plate was taken. 
2. A loop was taken and flamed before picking up a colony from subculture NA plate. 
3. Streak was done on the EMB plate. 
4. EMB plate was incubated overnight at 37ºC. 
5. Green sheen colonies should be seen the next day.  
The green sheen colonies are shown in figure 3.1 in the result section.  
2.3.2 Biochemical Tests: Biochemical tests were performed according to the procedures 
written in Microbiology Laboratory Manual [Cappuccino & Sherman, 2005]. The 
biochemical tests carried out were IMViC tests: indole production test, methyl-red test, 
Voges-Proskauer test and citrate utilization test. 
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a) Indole Production Test 
Some bacteria characteristically produce an enzyme called tryptophanase which converts 
tryptophan into indole and other metabolic products. When a media containing tryptophan as 
substrate is used, the conversion to indole can be detected by Kovac’s reagent. The reagent 
reacts with the converted indole and produces a cherry red color. Red reagent layer at the top 
determines the presence of indole producing culture, from tryptophan. Absence of red color 
indicates an indole negative reaction [Cappuccino & Sherman, 2005].  
1. Using sterile technique, a colony taken from NA was inoculated into an Indole tube, 
containing peptone broth by means of stab inoculation. 
2. The tube was inoculated overnight at 37ºC. 
3. After incubation, 10 drops of Kovac’s reagent were added and agitated gently. 
The result is shown in figure 3.2 in the result section.  
b) Methyl Red Test 
Some bacteria oxidize glucose as a major substrate to produce large quantities of acidic end 
products. This acidic property of the media is detected by a pH indicator, methyl red. The 
indicator shows red color when at pH 4 (positive reaction) and yellow at pH 6 (negative 
reaction) [Cappuccino & Sherman, 2005]. 
1. Using sterile technique, a colony taken from NA was inoculated into a tube, 
containing peptone, dextrose and potassium phosphate by means of loop inoculation. 
2. The tube was inoculated overnight at 37ºC. 
3. After incubation, 5 drops of Methyl Red reagent were added. 
The result is shown in figure 3.3 in the result section.  
c) Voges-Proskauer’s Test 
Utilizing the organic acids that result from glucose metabolism, some bacteria are able to 
nonacidic or neutral end products. Detection of the end product requires oxidation of it into a 
diacetyl compound. This reaction occurs in the presence of α-naphthol catalyst and a 
guanidine group that is present in the peptone of the MR-VP medium.The α-naphthol catalyst 
is found in Barritt’s reagent with a combination of 40% potassium hydroxide. The reaction 
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changes into a deep red color within 15 minutes of adding the reagent. The absence of color 
formation demonstrates a negative result [Cappuccino & Sherman, 2005].  
1. Using sterile technique, a colony taken from NA was inoculated into a tube, 
containing peptone, dextrose and potassium phosphate by means of loop inoculation. 
2. The tube was inoculated overnight at 37ºC. 
3. After incubation, 10 drops of Barritt’s A reagent were added, immediately followed 
by 10 more drops of Barritt’s B reagent. The mixture was shaken well every 3 to 4 
minutes. Result was recorded after 15 minutes.  
The result is shown in figure 3.4 in the result section.  
       d) Citrate Utilization Test 
Some microorganisms are able to utilize citrate with the help of citrate permease, an enzyme 
that facilitates the transport of citrate in the cell when other major substrates are scarce. Once 
the citrate is inside the cell, it is acted on by another enzyme, citrase. After a series of 
reactions, carbon dioxide is produced which changes the nature of the medium with the help 
of sodium and water. The production of sodium carbonate changes the bromothymol blue 
indicator incorporated into the medium from green to deep Prussian blue [Cappuccino & 
Sherman, 2005].  
1. Using sterile technique, a colony taken from NA was inoculated into a vial, 
containing a slant of Simmon’s Citrate agar by means of streak inoculation. 
2. The vial was inoculated overnight at 37ºC. 
3. Result observed after incubation.  
The result is shown in figure 3.5 in the result section.  
2.4 Preservation 
Preservation was done to protect the organism from contaminations during interruptions of 
laboratory works due to sample collection, holidays etc. For short term preservation, T1N1 
media was used. 
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2.4.1 Stock preparation  
1. T1N1 media was prepared and 1.5 ml was taken into vials. 
2. The vials were then autoclaved at 121ºC for 15 minutes. After autoclaving, they were 
kept at room temperature over night to gelatinize.  
3. The next day, two E. coli colonies were taken from the NA subculture plate with the 
help of a sterile loop to inoculate the gelatinized T1N1 media, by means of stab 
inoculation. Two vials were inoculated in this method. 
4. The vials were then incubated at 37ºC, overnight. 
      5.   After incubation, the top of the media inside the vials were layered with 200 µl sterile 
glycerol. The vials were sealed with parafilm and kept at room temperature. 
The growth of E. coli in T1N1 media is shown in figure 3.6 in the result section. 
2.5 Serum Collection 
Serum is the clear, yellow colored aqueous layer that can be isolated from clotted blood. It 
contains proteins of different types which participate in the defense mechanism of the body, 
called complement system. Serum is an environment in which bacterial cells should not exist. 
The serum complement system provides innate defense against microbial infections. It 
consists of at least 35 proteins, mostly in pre-activated enzymatic forms [Bugla-Ploskońska et 
al., 2009].   
2.5.1 Location and Sample Number 
Blood samples were collected mainly from two locations: 
1. BRAC University (Urban area): 50 sample 
2. T&T Slum (Slum area): 50 sample 
Figure 2.1: Collecting serum samples from BRAC 
University (Urban area) 
Figure 2.2: Collecting serum samples from T&T 
Slum (Slum area) 
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During the sample collection procedure the area concerning safety of the volunteers were 
taken seriously since blood drawing is an invasive process. Each step was performed with 
extra caution. Below are some of the precautions taken during this procedure: 
 Blood was collected with the help of an experienced nurse.  
 New gloves were worn. 
 Newly bought, sealed packet syringes were used to draw blood.  
 Hexisol and fresh cotton were used to disinfect the area from where blood was later 
drawn.  
 After drawing blood band aids were provided to the volunteers. 
 Blood samples were stored in autoclaved test tubes at appropriate temperature. 
 The used syringes were safely discarded so that other individuals as well as the 
environment do not come in contact with the potent dangers that might accompany 
bodily fluids.  
2.5.2 Procedure 
Serum isolation from the collected blood samples is 
one of the most important steps of the total 
procedure as this whole research work is based on 
serum activity. Serum collection procedure is 
elaborately described below: 
1. The 5 ml blood was kept in a slanted 
position for 1 hour at 37ºC, just after the 
collection. 
2. After the incubation the blood was kept at 
4ºC overnight in a standing position. 
3. The next day, the blood was split into 2 
layers, one of clotted blood (blood cells) and 
the other of serum which is a clear, 
yellowish, aqueous layer.  
4. 2 sterile micro centrifuge tubes were labeled 
according to the name of the individual to 
whom the blood sample belongs.  
Figure 2.3: Serum collection 
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5. The yellowish clear serum layer was transferred into one of the micro centrifuge 
tubes. This step was repeated until the whole layer had been transferred. The 
transferring was only stopped when blood cells started to contaminate the drawn out 
serum layer.  
6. To avoid the accidental blood cell in the isolated serum which may interfere with the 
serum activity, centrifugation at 3000 rpm for 10 minutes was done. This helps the 
remaining blood cells to form a precipitate, leaving a clear serum supernatant.  
7. After centrifugation, the serum supernatant was transferred into the other sterile, 
labeled micro centrifuge tube. 
The before and after serum isolation figures (figure number 3.7 and 3.8) are juxtaposed in the 
result section. 
Each serum sample was isolated following these steps. All these steps were performed inside 
a laminar flow cabinet to avoid any and all kinds of contamination. All the equipments like 
test tubes, micro pipette tips, micro centrifuge tubes etc were previously autoclaved. Each and 
every work was done with extra caution to eliminate unwanted contamination and errors.  
2.5.3 Survey 
Before collecting blood, each of the volunteers was asked to fill out a questionnaire. A 
completed questionnaire would provide information about name, age, sex, blood group, 
occupation, present clinical symptoms, vaccination, donor ship and food habit about the 
volunteer and also other information such as place and date of collection.  
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Figure 2.4: Questionnaire sample 
This survey was done to help understand the body condition of the volunteer and its effect on 
the individual’s serum activity. For e.g. if a volunteer is exposed to any diseases, if yes, then 
is the disease causing the serum to act differently than that of a healthy individual. It was kept 
in mind that each of the information can act as a factor that may or may not affect the serum 
activity.  The place of collection is the most important piece of information which helped, in 
comparing the two different population (urban and slum area) based on their life style. 
Overall, this survey serves the purpose of aiding, strengthening and supporting the research 
procedure and thus establishing an organized, data based result.  
2.5.4 Preservation 
The serum samples were stored at -20ºC.  
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2.6 Bactericidal activity of human serum against E. coli 
The serum activity testing procedure was divided into 3 parts, taking 3 days including 
observation of results. Below is the elaborate description of the procedure that had been 
followed for each individual serum. 
Some steps of the method used in a research paper titled, “Killing of Gram-Negative Bacteria 
with Normal Human Serum and Normal Bovine Serum: Use of Lysozyme and Complement 
Proteins in the Death of Salmonella Strains O48” in 2009 by G. Bugla-Ploskońska and his 
team, were modified and followed in this procedure. The steps are, 
1. The strains were grown overnight in YP medium and then 50 µl of the bacterial 
cultures was transferred to 3 ml of fresh YP medium and incubated at 37ºC for 1 h in 
a water bath [Bugla-Ploskońska et al., 2009]. 
2. After incubation the bacterial cells were centrifuged (2500xg for 20 min at 4°C) and 
suspended in physiological saline to obtain a six-fold dilution [Bugla-Ploskońska et 
al., 2009]. 
3. Then, the bacteria were mixed with NHS (Normal Human Serum). The serum was 
diluted with 0.1 M NaCl [Bugla-Ploskońska et al., 2009].  
4. The bacteria with serum were incubated in a water bath at 37ºC. [Bugla-Ploskońska et 
al., 2009]. 
5. After 0 (T0) and 180 (T3) min, the samples were collected, diluted and cultured on 
nutrient agar plates for 18 h at 37ºC. The bacteria were cultured in solidified agar 
medium in Petri dishes [Bugla-Ploskońska et al., 2009].  
6. The average number of colonies was estimated from the plates. [Bugla-Ploskońska et 
al., 2009]. 
2.6.1 Part 1 (Day 1):  
1. 5 ml of sterile nutrient broth was taken. 1.5 ml was transferred into a sterile 2 ml 
microcentrifuge tube and 0.5 ml was discarded.  
2. The rest of the 3 ml NB was inoculated with E. coli taken from the subculture with the 
help of a sterile loop. 
3. The inoculated test tube was kept in an incubator at 37ºC for 24 hours.  
4. The 2 ml microcentrifuge tube containing 1.5 ml NB was kept at 4ºC overnight. 
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2.6.2 Part 2 (Day 2):  
1. The next day after incubation, 25 µl of the E. coli culture was transferred to the 
previously stored fresh 1.5 ml NB containing microcentrifuge tube.  
2. The inoculated NB was incubated at 37ºC for 1 hour.  
3. After the 1 hour incubation, the bacterial cells were centrifuged at (2500xg for 20 min 
at 4°C) and suspended in physiological saline to obtain a six-fold dilution  
4. A new sterile microcentrifuge tube was taken for the preparation of serum-saline 
mixture. In this tube, 100 µl of serum and another 100 µl of sterile saline were taken. 
Thus a diluted serum mixture was prepared for the next steps. 
5. In another sterile microcentrifuge tube, 150 µl of the serum-saline mixture and 150 µl 
of the E. coli-saline mixture were taken. The mixture was mixed well. 
6. After 0 minute, 100 µl of the serum, saline & E. coli mixture was cultured on freshly 
prepared NA plate by means of spreading.  
7. The microcentrifuge tube containing rest of the serum, saline & E. coli mixture was 
incubated for 180 minutes.  
8. After 180 minutes incubation, 100 µl from the mixture was cultured on a new NA 
plate through spreading. The plates were then incubated at 37ºC overnight. 
2.6.3 Part 3 (Day 3):  
1. The next day, the 0 minute and 180 minutes plates were observed and results were 
recorded.  
The 0 minute and 180 minutes results of 5 serum samples from each area are shown in figure 
3.9 and 3.10 consecutively. 
All these steps were performed inside a laminar flow cabinet to avoid all kinds of 
contamination. All the mediums and equipments like NA, NB, NS, Petri plates, test tubes, 
micro pipette tips, micro centrifuge tubes etc were previously autoclaved and sterile. Each 
and every work was done with extra caution to eliminate unwanted contamination and errors.  
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3. Results 
3.1 Bacterial Strain 
 
 Figure 3.1: E. coli colonies on Nutrient Agar  
E. coli give colorless colonies on Nutrient Agar. To keep the bacteria viable and free from 
contamination, subculture was done on NA weekly, via the streaking procedure. 
3.2 Identification 
Identification of the bacteria was done for reconfirmation. E. coli was reconfirmed by 
streaking on a selective media and by performing biochemical tests.  
3.2.1 Selective Media 
E. coli strain provided by the laboratory was streaked on EMB agar, a selective media for E. 
coli to confirm the presence of the bacteria.  After overnight incubation at 37ºC, the growth 
was observed. The characteristic green sheen colonies of E. coli on EMB are shown in the 
figure given below.   
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Figure 3.2: Green sheen E. coli colonies on EMB 
As E. coli gives characteristic green sheen colonies on EMB, the presence of E. coli had been 
confirmed with this experiment.  
3.2.2 Biochemical Tests 
Isolate which gave metallic green sheen was subjected to different biochemical tests. The 
biochemical test results that the isolate showed were typical for E. coli. 
a) Indole Production Test 
 
Figure 3.3: Test tubes showing result for Indole production (negative control, positive control, 
isolate) 
 
Negative control Positive control Isolate positive on 
Indole test 
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b) Methyl Red Test 
 
Figure 3.4: Test tubes showing result for Methyl Red test (negative control, positive control, 
isolate) 
 
c) Voges-Proskauer’s Test 
 
Figure 3.5: Test tubes showing result for Voges-Proskauer test (negative control, positive 
control, isolate) 
 
 
 
Negative control Positive control Isolate positive on 
Methyl Red test 
 
Negative control Positive control Isolate negative on 
VogesProskauer 
test 
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d) Citrate Utilization Test 
 
Figure 3.6: Test tubes showing result for Citrate test (negative control, positive control, isolate) 
 
The selective media and biochemical test results ensure that the isolate tested here is of 
Escherichia coli. 
3.3 Preservation 
T1N1 media Preservation: T1N1 media was inoculated with E. coli for long term 
preservation. The freshly prepared media was inoculated, incubated at 37ºC overnight. After 
incubation, the media turned turbid in places where it had been stabbed with inoculated loop 
thus ensuring the growth of the bacteria.  
 
 
 
 
 
 
 
Figure 3.7: Inoculated T1N1 media 
Negative control Positive control Isolate negative on 
Citrate test 
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3.4 Serum collection 
 
After collection, the sample blood was subjected to 1 hour incubation at 37ºC and overnight 
refrigeration at 4ºC. After 24 hours, the separated layer of serum was collected into sterile 
microcentrifuge tubes and centrifuged until a fresh serum sample free from blood cells was 
isolated. 
3.5 Serum activity 
The following table shows the activity of serums collected from both urban and slum area, 
against E. coli at two different times. The 0 minute result usually shows a high count due to 
the lack of time which the serum needs to act upon the bacteria. But with time as the serum 
starts to inhibit the growth of the bacteria, the 180 minutes result shows a low count.  
 
 
 
Figure: Inoculated T1N1 agar 
Figure 3.8: Blood and serum in separate layers after 
overnight refrigeration 
Figure 3.9: Fresh serum after isolation 
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Table 2: The ability of 25 representative serum samples from urban area (BRAC 
University), to inhibit the growth of E. coli 
 
Sample 
Number 
Urban Area (BRAC University) 
No. of colonies at 0 minute No. of colonies at 180 minutes 
1 540 2 
2 304 1 
3 72 0 
4 1516 0 
5 10 0 
6 276 2 
7 3 0 
8 352 4 
9 568 3 
10 468 26 
11 328 1 
12 296 0 
13 45 0 
14 96 0 
15 45 0 
16 124 0 
17 58 0 
18 10 0 
19 204 0 
20 67 0 
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21 206 0 
22 390 0 
23 172 0 
24 620 0 
25 350 5 
 
Table 3: The ability of 25 representative serum samples from slum area (T&T Slum), to 
inhibit the growth of E. coli 
 
Sample 
Number 
Slum Area (T&T Slum) 
No. of colonies at 0 minute No. of colonies at 180 minutes 
1 2640 1 
2 808 3 
3 724 0 
4 1044 0 
5 1480 0 
6 1350 33 
7 1408 1 
8 1040 0 
9 232 1 
10 253 2 
11 1412 1 
12 2048 4 
13 736 1 
14 1688 0 
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15 1100 2 
16 320 0 
17 736 9 
18 261 0 
19 126 0 
20 128 0 
21 72 0 
22 142 0 
23 272 1 
24 128 0 
25 310 4 
  
Below are figures of serum complement activity of 5 serum samples from each area at 0 
minute and 180 minutes.  
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3.5.1 Five Serum Samples from Urban Area, BRAC University  
 
 
a) 
 
b) 
 
0 minute 180 minutes 
0 minute 180 minutes 
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c) 
 
d) 
 
0 minute 180 minutes 
180 minutes 0 minute 
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 e) 
Figure 3.10:  
a) Urban serum sample 1 activity at 0 minute & at 180 minutes 
b) Urban serum sample 2 activity at 0 minute & at 180 minutes 
c) Urban serum sample 3 activity at 0 minute & at 180 minutes 
d) Urban serum sample 4 activity at 0 minute & at 180 minutes 
e) Urban serum sample 5 activity at 0 minute & at 180 minutes 
 
 
Figure 3.11: Graphical Representation of Complement Activity of Different Serum Samples 
(BRAC University) against E. coli at 0 Minute and 180 Minutes 
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3.5.2Five Serum Samples from Slum Area, T&T Slum 
 
 a) 
 
 b) 
0 minute 
0 minute 
180 minutes 
180 minutes 
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 c) 
 
 d) 
0 minute 
0 minute 
180 minutes 
180 minutes 
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 e) 
Figure 3.12:  
a) Slum serum sample 1 activity at 0 minute & at 180 minutes 
b) Slum serum sample 2 activity at 0 minute & at 180 minutes 
c) Slum serum sample 3 activity at 0 minute & at 180 minutes 
d) Slum serum sample 4 activity at 0 minute & at 180 minutes 
e) Slum serum sample 5 activity at 0 minute & at 180 minutes 
 
Figure 3.13: Graphical Representation of Complement Activity of Different Serum Samples (T&T Slum) 
against E. coli at 0 Minute and 180 Minutes 
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Figure 3.14: Graphical Representation of Analysis of the Average Serum Complement Activity 
against E. coli at 0 Minute and 180 Minutes of Both Urban and Slum Area Samples 
 
 
Figure 3.15: Graphical Representation of Comparison of Percentage Inhibition of E. coli 
Caused by Serum (Complement), Collected from Different Areas 
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4. Discussion and Conclusion 
Despite of being a beneficial gut flora, Escherichia coli threatens humans with various 
diseases. E. coli has proved to be one of the major causes of mild and severe diarrhea [Bower 
et al., 1999]. Since the organism is adapted to thrive in the intestinal environment, the 
incidence of intestinal diseases caused by the species is high than that of others. But with 
time E. coli has been able to expand its habitat in the human body and has been able to cause 
diseases like urinary tract infections, bacterimia, cholangitis, pneumonia, neonatal meningitis 
etc [Madappa, 2015]. There is now no reason to take this organism lightly since it has the 
potential to cause diseases that can be fatal.  
As E. coli is a normal flora of the intestines of animals, the organism is found abundantly in 
the environment through feces. So each and every individual comes in contact with it. 
Intestinal diseases with higher prevalence than other E. coli related diseases, occur when the 
organism enters human body through fecal contaminated food, water etc. E. coli related 
enteric infections have a greater prevalence in Bangladesh than most diseases. 34% of the 
diarrhea related infections are caused by the diarrheal E. coli in Bangladesh. Bangladesh 
being a densely populated, small developing country, a large portion of the population is 
living below the poverty line. Naturally this part of the population is more exposed to the 
organism than those who are well off. It can be assumed that people who are living in slums 
would be more adapted to E. coli than those who do not. This study is reporting if the 
different lifestyle of the two sections of the population (one living in urban area, the other in 
slum area) of Bangladesh has any affect on the complement inhibition activity of the serums 
collected from both the places against E. coli. The comparative complement activity can be 
obtained from the column charts from the result section. 
In “Analysis of the Average Complement Activity against E. coli at 0 Minute and 180 
Minutes Among Urban and Slum Area” (fig. 3.13) chart, the average of the cell counts of 50 
serum samples, both at 0 minute and 180 minutes was taken. This was done for both urban 
and slum area samples. The columns show that the complement inhibition of the slum area 
samples was much greater than that of the urban area samples. For better understanding 
another column chart was prepared, “Comparison of Percentage Inhibition of E. coli Caused 
by Serum (Complement), Collected from Different Areas” (fig. 3.14) from the previous chart 
where the complement mediated inhibition of E. coli cells of both the population was 
presented as percentages. This column chart clearly shows the difference between urban and 
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slum area complement mediated inhibition. Urban area serum samples were able to inhibit E. 
coli cells at approximately 87.59%. On the other hand slum area serum samples were able to 
inhibit E. coli cells at approximately 99.67%.  
Both the charts reveal that the differences in living condition or life style do affect the 
complement mediated inhibition activity of human serum. Both the urban and slum 
population more or less has been exposed to E. coli but the slum population has adapted to 
the organism since they are more exposed to it through poor living condition. The 
complement system of their serum has been able to kill off more of the organism. Thus the 
slum population is able to show greater resistance than that of urban people against E. coli. 
The people living in slums can be more exposed to various potentially pathogen organisms 
due to a different lifestyle than people who live in the urban area but this exposure may 
actually aid the slum people in having a better immunity.  
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APPENDICES 
 
APPENDIX-I 
 
Media composition 
 
The composition of the media used in the present study has been given below. Unless 
otherwise mentioned, all the media were autoclaved at 121ºC for 15 min. 
1. Nutrient Agar (Himedia, India) 
Ingredients Amount (g/L) 
Peptic digest of animal tissue 5.0 
Beef Extract 1.50 
Sodium chloride 5.0 
Yeast extract 1.50 
Agar 15.0 
 
2. Nutrient Broth (Oxoid, England) 
Ingredients Amount(g/L) 
Lab-lemcopowder 1.0 
Yeastextract 2.0 
Peptone 5.0 
Sodiumchloride 5.0 
 
3. T1N1 soft agar 
Ingredients Amount(g/L) 
Tryptone     0.6 g 
Sodiumchloride 0.3g 
Agar      0.42 g 
 
 
 
II | P a g e  
Appendices 
4. Simmon’s citrate agar (Oxoid, England) 
Ingredients Amount(g/L) 
Magnesiumsulfate 0.2 
Ammonium dihydrogenphosphate 0.2 
Ammoniumphosphate 0.8 
Sodiumcitrate 2.0 
Sodiumchloride 5.0 
Agar 15.0 
Bactobromthymolblue 0.08 
 
5. MR-VP broth 
Ingredients Amount(g/L) 
Peptone 7 g 
Dextrose 5 g 
Potassiumphosphate 5 g 
 
6. Eosine methylene blue agar (Oxoid, England) 
Ingredients Amount(g/L) 
Peptone 10.0 
Sucrose 5.0 
Lactose 5.0 
Di-potassiumphosphate 2.0 
EosinY 0.14 
Methyleneblue 0.065 
Agar 13.50 
 
7. Peptone Water 
Ingredients Amount(g/L) 
Peptone 10.0 
Sodium Chloride 5.0 
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APPENDIX-II 
 
Buffers and Reagents 
 
1. Kovac’s reagent 
5 g of para-dimethylaminobenzaldehyde was dissolved in 75 ml of amyl alcohol. Then 
concentrated HCl was added to make the final volume 25 ml. This reagent was covered with 
aluminum foil and stored at 4ºC. 
2. Methyl red reagent 
0.1 g of methyl red was dissolved in 300 ml of 95% ethyl alcohol. Then distilled water was 
added to make the final volume 500 ml. This reagent was covered with aluminum foil and 
stored at 4ºC. 
3. Barritt’s reagent 
Solution A 
5 g of alpha-naphthol was dissolved in 95% ethanol. This solution was covered with 
aluminum foil and stored at 4ºC. 
Solution B 
40 g of KOH was dissolved in distilled water. The solution became warm. After cooling to 
room temperature, creatine was dissolved by stirring. Distilled water was added. This 
solution was covered with aluminum foil and stored at4ºC.  
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APPENDIX-III 
Instruments 
The important equipments used through the study are listed below: 
 
Serial 
Number 
Name of Item Specification 
1 Autoclave Model: HL-340, Gemmy Industrial 
Cor.,  
Taiwan 
 
2 Freezer(-20°C) Siemens, Germany 
3 Incubator Model: DSI500D, Taiwan 
4 Micropipette(2-20 µl) Eppendorf, Germany 
5 Micropipette(20-200 µl) Eppendorf, Germany 
6 Micropipette(100-1000 µl) Eppendorf, Germany 
7 Oven (Microwave oven) Model: MH6548SR, LG China 
8 Refrigerator (4oC) Model: 0636, Samsung 
9 Balance Radwag, WTB200 
10 Centrifuge 
(High speed refrigerated 
micro centrifuge) 
 
Model: GAM 1.5-24 Scanspeed 1730,  
Denmark 
11 Vortex Mixture VM-2000, digisystem, Taiwan 
12 Hot air oven (Sterilizer) Model: 02G, Jero Tech, Korea 
13 Laminar air flow cabinet SAARC 
14 Shaking incubator Model: WIS-20R, Daihan Scientific, 
Korea 
15      Disposable micropipette tips  
 
     Eppendorf, Ireland 
 
